drugset / Trial / NCT06426160
Tocilizumab for Painful Chronic Pancreatitis
Phase 2
Unknown
36 enrolled
Soren Schou Olesen
Aarhus University Hospital · collabHaukeland University Hospital · collabStanford University · collabUniversity of Aarhus · collabViborg Regional Hospital · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This placebo-controlled study will investigate the effect of tocilizumab (an anti-interleukin-6 receptor antibody) on symptom burden, physical functioning, and quality of life in patients with chronic pancreatitis.
Timeline
- Start
- 2024-05-21
- Primary completion
- 2026-06
- Completion
- 2026-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tocilizumab | Monoclonal antibody | 8 mg/kg | — |